P3-10-01: Alternative Dosing Regimens with the EGFr Inhibitors (Gefitinib and Lapatinib) in Mammary Cancer Models: Prevention and Therapeutic Efficacy.

2011 ◽  
Author(s):  
RA Lubet ◽  
AM Bode ◽  
E Szabo ◽  
CJ Grubbs
Keyword(s):  
Therapeutic Efficacy ◽  
Mammary Cancer ◽  
Egfr Inhibitors ◽  
Cancer Models ◽  
Dosing Regimens

scholarly journals Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKt inhibitor MK2206 in mammary cancer models

2018 ◽  
Author(s):  
Ronald Lubet ◽  
Vernon Steele ◽  
M. Juliana ◽  
Ann Bode ◽  
Fariba Moeinpour ◽  
...  
Keyword(s):  
Mammary Cancer ◽  
Egfr Inhibitors ◽  
Akt Inhibitor ◽  
Cancer Models

scholarly journals [Corrigendum] Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKT inhibitor�MK2206 in mammary cancer models

2018 ◽  
Author(s):  
Ronald Lubet ◽  
Vernon Steele ◽  
M. Juliana ◽  
Ann Bode ◽  
Fariba Moeinpour ◽  
...  
Keyword(s):  
Mammary Cancer ◽  
Egfr Inhibitors ◽  
Akt Inhibitor ◽  
Cancer Models

Short-term Modulation of Cell Proliferation and Apoptosis and Preventive/Therapeutic Efficacy of Various Agents in a Mammary Cancer Model

2007 ◽  
Vol 13 (18) ◽  
pp. 5488-5496 ◽  
Author(s):  
Konstantin Christov ◽  
Clinton J. Grubbs ◽  
Anne Shilkaitis ◽  
M. Margaret Juliana ◽  
Ronald A. Lubet
Keyword(s):  
Cell Proliferation ◽  
Therapeutic Efficacy ◽  
Mammary Cancer ◽  
Cancer Model ◽  
Short Term ◽  
Proliferation And Apoptosis ◽  
Mammary Cancer Model

Antitumour activity of coumarin in prostate and mammary cancer models

1994 ◽  
Vol 120 (S1) ◽  
pp. S14-S16 ◽  
Author(s):  
E. von Angerer ◽  
M. Kager ◽  
A. Maucher
Keyword(s):  
Mammary Cancer ◽  
Antitumour Activity ◽  
Cancer Models

Abstract LB-212: Therapeutic efficacy of the paradox-breaking panRAF and SRC drug CCT3833/BAL3833 in KRAS-driven cancer models

2016 ◽  
Author(s):  
Grazia Saturno ◽  
Filipa Lopes ◽  
Maria Romina Girotti ◽  
Ion Niculescu-Duvaz ◽  
Dan Niculescu-Duvaz ◽  
...  
Keyword(s):  
Therapeutic Efficacy ◽  
Cancer Models

Abstract 2171: Activatable nanodelivery of high payload gemcitabine augments therapeutic efficacy in murine breast and pancreatic cancer models

2019 ◽  
Author(s):  
Samantha T. Tucci ◽  
Azadeh Kheirolomoom ◽  
Elizabeth S. Ingham ◽  
Lisa M. Mahakian ◽  
Sarah M. Tam ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Therapeutic Efficacy ◽  
Cancer Models ◽  
High Payload
Sign in / Sign up

Export Citation Format

Share Document